Skip to main content
TipRanks
Go Ultimate75% OFF

Zimmer Biomet Holdings (0QQD) Stock Statistics & Valuation Metrics

1 Followers

Total Valuation

Zimmer Biomet Holdings has a market cap or net worth of CHF 16.14B. The enterprise value is CHF 24.12B.

Market Cap
CHF 16.14B
Enterprise Value
CHF 24.12B

Share Statistics

Zimmer Biomet Holdings has 189,253,890 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
189,253,890
Owned by Insiders
0.17%
Owned by Institutions
90.17%

Financial Efficiency

Zimmer Biomet Holdings’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 5.48%.

Return on Equity (ROE)
0.06
Return on Assets (ROA)
0.03
Return on Invested Capital (ROIC)
5.48%
Return on Capital Employed (ROCE)
0.07
Revenue Per Employee
484.21K
Profits Per Employee
41.48K
Employee Count
17,000
Asset Turnover
0.36
Inventory Turnover
1.38

Valuation Ratios

The current PE Ratio of Zimmer Biomet Holdings is 25.65. Zimmer Biomet Holdings’s PEG ratio is -11.57.

PE Ratio
25.65
PS Ratio
2.25
PB Ratio
1.52
Price to FCF
11.63
Price to Operating Cash Flow
10.29
PEG Ratio
-11.57

Income Statement

In the last 12 months, Zimmer Biomet Holdings had revenue of 8.23B and earned 705.20M in profits. Earnings per share was 3.56.

Revenue
8.23B
Gross Profit
5.07B
Operating Income
1.36B
Pretax Income
830.80M
Net Income
705.20M
EBITDA
2.22B
Earnings Per Share (EPS)
3.56

Cash Flow

In the last 12 months, operating cash flow was 1.88B and capital expenditures -227.90M, giving a free cash flow of 1.66B billion.

Operating Cash Flow
1.88B
Free Cash Flow
1.66B
Free Cash Flow per Share
8.70

Dividends & Yields

Zimmer Biomet Holdings pays an annual dividend of ―, resulting in a dividend yield of 1.08%

Dividend Per Share
―
Dividend Yield
1.08%
Payout Ratio
N/A
Free Cash Flow Yield
8.63%
Earnings Yield
3.97%

Stock Price Statistics

Beta
0.04
52-Week Price Change
0.00%
50-Day Moving Average
77.38
200-Day Moving Average
77.38
Relative Strength Index (RSI)
―
Average Volume (3m)
―

Important Dates

Zimmer Biomet Holdings upcoming earnings date is Feb 11, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 04, 2026
Next Earnings Date
Feb 11, 2027
Ex-Dividend Date
―

Financial Position

Zimmer Biomet Holdings as a current ratio of 1.98, with Debt / Equity ratio of 59.22%

Current Ratio
1.98
Quick Ratio
1.10
Debt to Market Cap
0.42
Net Debt to EBITDA
3.12
Interest Coverage Ratio
4.65

Taxes

In the past 12 months, Zimmer Biomet Holdings has paid 125.70M in taxes.

Income Tax
125.70M
Effective Tax Rate
0.15

Enterprise Valuation

Zimmer Biomet Holdings EV to EBITDA ratio is 11.50, with an EV/FCF ratio of 15.88.

EV to Sales
3.07
EV to EBITDA
11.50
EV to Free Cash Flow
15.88
EV to Operating Cash Flow
13.96

Balance Sheet

Zimmer Biomet Holdings has CHF 399.90M in cash and marketable securities with CHF 7.50B in debt, giving a net cash position of -CHF 7.10B billion.

Cash & Marketable Securities
CHF 399.90M
Total Debt
CHF 7.50B
Net Cash
-CHF 7.10B
Net Cash Per Share
-CHF 37.54
Tangible Book Value Per Share
-CHF 11.79

Margins

Gross margin is 69.68%, with operating margin of 15.11%, and net profit margin of 8.96%.

Gross Margin
69.68%
Operating Margin
15.11%
Pretax Margin
10.32%
Net Profit Margin
8.96%
EBITDA Margin
26.67%
EBIT Margin
13.76%

Analyst Forecast

The average price target for Zimmer Biomet Holdings is CHF 98.21, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
CHF 98.21
Price Target Upside
26.93% Upside
Analyst Consensus
Moderate Buy
Analyst Count
17
Revenue Growth Forecast
0.21%
EPS Growth Forecast
-8.55%

Scores

Smart Score
6
AI Score
―